Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Tazarotene Cream vs Tazorac in Plaque Psoriasis
NCT02160665Phase 3Completed
- Sponsor
- G&W Laboratories
- Start
- May 2014
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tazarotene in plaque psoriasis, sponsored by G&W Laboratories. Started May 2014; status: completed.
02
Drugs
tazarotene
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02160665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160665.